2023-04-01 11069157 2024-03-31 11069157 2023-04-01 2024-03-31 11069157 2023-03-31 11069157 2022-04-01 2023-03-31 11069157 uk-core:WithinOneYear 2023-03-31 11069157 uk-core:WithinOneYear 2024-03-31 11069157 uk-core:AfterOneYear 2023-03-31 11069157 uk-core:AfterOneYear 2024-03-31 11069157 uk-core:ShareCapital 2024-03-31 11069157 uk-core:ShareCapital 2023-03-31 11069157 uk-core:SharePremium 2024-03-31 11069157 uk-core:SharePremium 2023-03-31 11069157 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 11069157 uk-core:RetainedEarningsAccumulatedLosses 2023-03-31 11069157 uk-core:OtherMiscellaneousReserve 2024-03-31 11069157 uk-bus:Director1 2023-04-01 2024-03-31 11069157 uk-bus:Director2 2023-04-01 2024-03-31 11069157 uk-core:Buildings 2023-04-01 2024-03-31 11069157 uk-core:PlantMachinery 2023-04-01 2024-03-31 11069157 uk-core:ComputerEquipment 2023-04-01 2024-03-31 11069157 uk-core:MotorVehicles 2023-04-01 2024-03-31 11069157 uk-core:FurnitureFittings 2023-04-01 2024-03-31 11069157 uk-core:ComputerEquipment 2023-03-31 11069157 uk-core:FurnitureFittings 2023-03-31 11069157 uk-core:MotorVehicles 2023-03-31 11069157 uk-core:PlantMachinery 2023-03-31 11069157 uk-core:Buildings 2023-03-31 11069157 uk-core:Buildings 2024-03-31 11069157 uk-core:MotorVehicles 2024-03-31 11069157 uk-core:FurnitureFittings 2024-03-31 11069157 uk-core:ComputerEquipment 2024-03-31 11069157 uk-core:PlantMachinery 2024-03-31 11069157 uk-core:WithinOneYear 2024-03-31 11069157 uk-core:WithinOneYear 2023-03-31 11069157 uk-core:AfterOneYear uk-core:Secured 2024-03-31 11069157 uk-core:AfterOneYear uk-core:Secured 2023-03-31 iso4217:GBP xbrli:pure 11069157 uk-bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11069157 uk-bus:FRS102 2023-04-01 2024-03-31 11069157 uk-bus:FilletedAccounts 2023-04-01 2024-03-31 11069157 uk-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
Brampton Medical Ltd
Registered Number:11069157
For the year ended 31 March 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 31 March 2024
Brampton Medical Ltd
Contents Page
1
Statement of Financial Position
2 to 5
Notes to the Financial Statements
3
Registered Number :
11069157
As at 31 March 2024
Brampton Medical Ltd
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
494,126
465,758
2
494,126
465,758
Current assets
Inventories
2,000
2,000
3
Trade and other receivables
30,036
23,633
4
21,425
Cash and cash equivalents
85,546
111,179
53,461
Trade and other payables: amounts falling due within one year
(311,687)
(322,774)
5
(258,226)
(211,595)
Net current liabilities
Total assets less current liabilities
282,531
207,532
Trade and other payables: amounts falling due after more than
one year
(36,337)
(60,977)
6
(25,796)
(19,806)
Provisions for liabilities
195,758
Net assets
151,389
Capital and reserves
Called up share capital
104
104
Share premium account
32,480
32,480
Retained earnings
163,154
118,785
Other reserves
20
20
195,758
151,389
Shareholders' funds
For the year ended 31 March 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
1 of 5
4
Registered Number :
11069157
For the year ended 31 March 2024
Brampton Medical Ltd
Statement of Financial Position Continued
Ms Elizabeth Anne Eleanor Gillow Director
Mr John Timothy Joseph Gillow Director
These financial statements were approved and authorised for issue by the Board on 25 September 2024 and were signed by:
The notes form part of these financial statements
2 of 5
5
For the year ended 31 March 2024
Brampton Medical Ltd
Notes to the Financial Statements
Statutory Information
Brampton Medical Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number
11069157.
Registered address:
36 Hanover Street
Newcastle Under Lyme
Staffordshire
ST5 1AU
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting
Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006.
The financial statements have been prepared under the historical costs convention as modified by the revaluation of certain
assets.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes.
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: There has been a change in accounting estimate, plant and machinery is now depreciated on a 20% reducing balance basis, previously a 10% straight line basis.
Land and Buildings
0% Straight line
Plant and Machinery
20% Reducing balance
33% Reducing balance
Computer Equipment
25% Reducing balance
Motor Vehicles
20% Straight line
Furniture and Fittings
Inventories
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable.
3 of 5
6
For the year ended 31 March 2024
Brampton Medical Ltd
Notes to the Financial Statements Continued
2. Property, plant and equipment
Total
Computer
Equipment
Furniture and
Fittings
Motor Vehicles
Plant and
Machinery
Land and
Buildings
£
£
£
£
£
£
Cost or valuation
At 01 April 2023
557,551
8,682
50,011
29,072
78,769
391,017
57,740
381
-
-
57,359
-
Additions
At 31 March 2024
391,017
29,072
50,011
9,063
615,291
136,128
Provision for depreciation and impairment
At 01 April 2023
91,793
4,433
43,719
12,719
30,922
-
Charge for year
29,372
1,529
2,713
4,088
21,042
-
At 31 March 2024
121,165
5,962
46,432
16,807
51,964
-
At 31 March 2024
Net book value
391,017
84,164
12,265
3,579
3,101
494,126
391,017
47,847
16,353
6,292
4,249
465,758
At 31 March 2023
3. Inventories
2023
2024
£
£
Stocks
2,000
2,000
4. Trade and other receivables
2023
2024
£
£
Trade debtors
11,810
10,880
Other debtors
11,823
19,156
30,036
23,633
5. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Bank loans and overdraft
5,363
5,231
Trade creditors
2,726
500
Taxation and social security
6,155
18,127
Other creditors
308,530
287,829
322,774
311,687
4 of 5
7
For the year ended 31 March 2024
Brampton Medical Ltd
Notes to the Financial Statements Continued
6. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Bank loans and overdraft
30,977
36,337
Other creditors
30,000
-
60,977
36,337
7. Related party transactions
Included within other creditors is the directors loan account balance of £305,017 (2023 £284,353). This loan is interest free
with no fixed date of repayment.
8. Average number of persons employed
During the year the average number of employees was 6 (2023 : 5)
5 of 5